AMINA JAWAID AGACNP
Prescription History 1942908892
Nurse Practitioner - Acute Care in Oklahoma City, OK

Active since February 20, 2023PECOS EnrolledAccepts Medicare Assignment
3300 NW EXPRESSWAY FL 1, OKLAHOMA CITY, OK 73112(405) 949-3349(405) 945-5467 Get Directions

NPPES record last updated: May 10, 2023. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: May 10, 2023, Feb 20, 2023 (2 updates tracked since 2023).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for AMINA JAWAID AGACNP, an active Acute Care specialist practicing in Oklahoma City, OK. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 116 documented patient claims. Among these therapy options, the most frequently utilized medication is Epclusa, which accounts for 42 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

4
Medications
116
Total Claims
154
30-Day Fills
Epclusa
Most Prescribed · 42 claims
View details
4 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by AMINA JAWAID AGACNP in 2024, with prescription volumes, average cost per fill, and OK state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other OK PrescribersVs. OK Avg

About Epclusa: This medication is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Show more ▾

It may sometimes be used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. It is not known if this treatment can prevent you from passing the virus to others. Do not share needles, and practice "safer sex" (including the use of latex condoms) to lower the risk of passing the virus to others. A combined pharmaceutical preparation of the antiviral agents sofosbuvir and valpatasvir that is used to treat all six major genotypes of HEPATITIS C VIRUS (HCV) infections.

In 2024, this provider wrote 42 Medicare prescriptions for Epclusa, about 2.3 times the volume of the typical Oklahoma prescriber of this medication (18.6). Medicare paid an average of $23,901.65 per fill, versus $23,934.68 statewide.

How often this provider prescribes it

This provider
42
OK average
18.6

This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$23,901.65
OK average
$23,934.68

This provider's average cost per fill is below the OK average for this medication.

42
30-Day Fills
standardized to 30-day supplies
1,176
Days of Medication
total across all patients in 2024

About Ursodiol: Ursodiol is used to dissolve certain types of gallstones, to prevent gallstones from forming in obese patients who are losing weight rapidly, and to treat a certain type of liver disease (primary biliary cholangitis). Show more ▾

Ursodiol is a bile acid. An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.

In 2024, this provider wrote 28 Medicare prescriptions for Ursodiol, about 89% of the volume of the typical Oklahoma prescriber of this medication (31.4). Medicare paid an average of $74.50 per fill, versus $121.94 statewide.

How often this provider prescribes it

This provider
28
OK average
31.4

This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$74.50
OK average
$121.94

This provider's average cost per fill is below the OK average for this medication.

40.3
30-Day Fills
standardized to 30-day supplies
1,210
Days of Medication
total across all patients in 2024

About Carvedilol: Carvedilol is used to treat high blood pressure and heart failure. Show more ▾

It is also used after a heart attack to improve the chance of survival if your heart is not pumping well. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect lowers your heart rate, blood pressure, and strain on your heart. Carvedilol belongs to a class of drugs known as alpha and beta blockers. A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION.

In 2024, this provider wrote 24 Medicare prescriptions for Carvedilol, about a third of the volume of the typical Oklahoma prescriber of this medication (76.8). Medicare paid an average of $3.17 per fill, versus $10.23 statewide.

How often this provider prescribes it

This provider
24
OK average
76.8

This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3.17
OK average
$10.23

This provider's average cost per fill is below the OK average for this medication.

40
30-Day Fills
standardized to 30-day supplies
1,200
Days of Medication
total across all patients in 2024

About Tenofovir Disoproxil Fumarate: Tenofovir is used with other HIV medications to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Tenofovir belongs to a class of drugs known as nucleotide reverse transcriptase inhibitors (NRTIs). Tenofovir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. Tenofovir is also used to treat a certain type of liver infection called chronic hepatitis B infection. It helps to decrease the amount of hepatitis B virus in your body by interfering with virus growth. An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.

In 2024, this provider wrote 22 Medicare prescriptions for Tenofovir Disoproxil Fumarate, about the same volume as the typical Oklahoma prescriber of this medication (20.7). Medicare paid an average of $112.83 per fill, versus $118.56 statewide.

How often this provider prescribes it

This provider
22
OK average
20.7

This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$112.83
OK average
$118.56

This provider's average cost per fill is below the OK average for this medication.

32
30-Day Fills
standardized to 30-day supplies
960
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average OK prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the OK average cost per fill.

About this data. The prescription history for AMINA JAWAID AGACNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Acute Care prescribing approach at this Oklahoma City, OK practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OK prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.